ALOX15 and gastric cancer: In gastric cancer, Zhang et al. [40] found that cisplatin and paclitaxel promoted the secretion of miR-522 from CAFs by activating the USP7/hnRNPA1 axis, and ultimately lead to chemotherapy resistance by targeting ALOX15 and blocking the accumulation of lipid ROS in cancer cells.